powerpoint presentationref-inst.org/wp-content/uploads/2019/11/digital_health_1.1.pdfpowerpoint...
TRANSCRIPT
How Millennial Doctors Are Transforming Medicine
"Nusinersen launched at a price of $750,000 for the first year and $375,000 for every year thereafter.
The gene therapy costs $2.1 million for a single dose; its manufacturer, the Novartis subsidiary AveXis, makes the case that the therapy is actually less expensive than treating
a patient with nusinersen for five years."
NeurologyToday: מתוך
The High Priced SMA Therapies Are Here.
Now How Are People Going to Pay for Them?
